Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers - PubMed (original) (raw)

Review

Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers

Wei Wang et al. Mol Neurobiol. 2015 Dec.

Abstract

Intracerebral hemorrhagic transformation (HT) is well recognized as a common cause of hemorrhage in patients with ischemic stroke. HT after acute ischemic stroke contributes to early mortality and adversely affects functional recovery. The risk of HT is especially high when patients receive thrombolytic reperfusion therapy with tissue plasminogen activator, the only available treatment for ischemic stroke. Although many important publications address preclinical models of ischemic stroke, there are no current recommendations regarding the conduct of research aimed at understanding the mechanisms and prediction of HT. In this review, we discuss the underlying mechanisms for HT after ischemic stroke, provide an overview of the models commonly used for the study of HT, and discuss biomarkers that might be used for the early detection of this challenging clinical problem.

Keywords: Blood-brain barrier; Hemorrhagic transformation; Ischemic stroke; Tissue plasminogen activator.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have no conflict of interest.

Similar articles

• Thrombolysis in dementia patients with acute stroke: is it justified?
  Paciaroni M, Pantoni L. Paciaroni M, et al. Neurol Sci. 2017 Jan;38(1):27-31. doi: 10.1007/s10072-016-2725-4. Epub 2016 Oct 3. Neurol Sci. 2017. PMID: 27699498 Review.
• The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
  Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA; SITS International and VISTA-plus investigators. Flint AC, et al. Int J Stroke. 2014 Aug;9(6):705-10. doi: 10.1111/ijs.12335. Epub 2014 Jul 15. Int J Stroke. 2014. PMID: 25042855
• Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.
  Messé SR, Pervez MA, Smith EE, Siddique KA, Hellkamp AS, Saver JL, Bhatt DL, Fonarow GC, Peterson ED, Schwamm LH. Messé SR, et al. Stroke. 2013 May;44(5):1354-9. doi: 10.1161/STROKEAHA.111.671966. Epub 2013 Mar 14. Stroke. 2013. PMID: 23493734
• Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
  Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, Alvarez-Sabín J. Ribo M, et al. Stroke. 2004 Sep;35(9):2123-7. doi: 10.1161/01.STR.0000137608.73660.4c. Epub 2004 Jul 8. Stroke. 2004. PMID: 15243150
• Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.
  Lansberg MG, Albers GW, Wijman CA. Lansberg MG, et al. Cerebrovasc Dis. 2007;24(1):1-10. doi: 10.1159/000103110. Epub 2007 May 22. Cerebrovasc Dis. 2007. PMID: 17519538 Review.

Cited by

• Hemorrhagic transformation after acute ischemic stroke caused by polycythemia vera: Report of two case.
  Cao YY, Cao J, Bi ZJ, Xu SB, Liu CC. Cao YY, et al. World J Clin Cases. 2021 Sep 6;9(25):7551-7557. doi: 10.12998/wjcc.v9.i25.7551. World J Clin Cases. 2021. PMID: 34616825 Free PMC article.
• Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat.
  Liddle L, Reinders R, South S, Blacker D, Knuckey N, Colbourne F, Meloni B. Liddle L, et al. PLoS One. 2019 Nov 7;14(11):e0224870. doi: 10.1371/journal.pone.0224870. eCollection 2019. PLoS One. 2019. PMID: 31697775 Free PMC article.
• Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator.
  Knecht T, Borlongan C, Dela Peña I. Knecht T, et al. Brain Circ. 2018 Jul-Sep;4(3):99-108. doi: 10.4103/bc.bc_21_18. Epub 2018 Oct 9. Brain Circ. 2018. PMID: 30450415 Free PMC article. Review.
• Hyponatremia Is Associated With Post-thrombolysis Hemorrhagic Transformation and Poor Clinical Outcome in Ischemic Stroke Patients.
  He L, Guo ZN, Qu Y, Jin H. He L, et al. Front Mol Neurosci. 2022 Jul 18;15:879863. doi: 10.3389/fnmol.2022.879863. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35923753 Free PMC article.
• Association between malnutrition risk and hemorrhagic transformation in patients with acute ischemic stroke.
  Yuan CX, Zhang YN, Chen XY, Hu BL. Yuan CX, et al. Front Nutr. 2022 Oct 5;9:993407. doi: 10.3389/fnut.2022.993407. eCollection 2022. Front Nutr. 2022. PMID: 36276820 Free PMC article.

References

1. 1. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke. 2002;33(3):831–836. - PubMed
2. 1. Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol. 2003;28(3):229–244. - PubMed
3. 1. Nour M, Scalzo F, Liebeskind DS. Ischemia-reperfusion injury in stroke. Interv Neurol. 2013;1(3–4):185–199. - PMC - PubMed
4. 1. Hong JM, Lee JS, Song HJ, Jeong HS, Choi HA, Lee K. Therapeutic hypothermia after recanalization in patients with acute ischemic stroke. Stroke. 2014;45(1):134–140. - PubMed
5. 1. Jickling GC, Liu D, Stamova B, Ander BP, Zhan X, Lu A, Sharp FR. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34(2):185–199. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

• K01AG031926/AG/NIA NIH HHS/United States
• R01AT007317/AT/NCCIH NIH HHS/United States
• R01NS078026/NS/NINDS NIH HHS/United States
• R01 AT007317/AT/NCCIH NIH HHS/United States
• R01 NS078026/NS/NINDS NIH HHS/United States
• K01 AG031926/AG/NIA NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Miscellaneous

  • NCI CPTAC Assay Portal